Senate passes Ujifusa bill to protect

patients’ pharmacy options

 

STATE HOUSE – The Senate today passed a bill sponsored by Sen. Linda Ujifusa that protects patients from an insurance scheme called “white bagging” that interferes with how prescribed drugs are delivered and administered.

White bagging refers to a practice where insurers require patients to get their prescriptions from insurer-affiliated pharmacies that are often mail order-only. The bill (2023-S 0870) would prohibit this practice.

Traditionally, if a patient needs a clinician-administered medication, such as a chemotherapy drug, the patient goes to the hospital where the clinician orders the needed drug from the on-site pharmacy and administers the medication.

According to the American Hospital Association, white bagging causes multiple problems. The practice is not sensitive to necessary changes in patient care plans. A health care provider often decides the patient needs a different dosage or a different drug after reviewing a patient’s labs or measurements on the day of treatment. Even though the hospital has these medications on site at their own pharmacy, they must wait for the drug to arrive from the specialty pharmacy or not get reimbursed. In addition, once filled and labeled, expensive specialty drugs cannot be substituted or modified. If the care plan is changed, often the drugs must be discarded.

Senator Ujifusa’s bill would prohibit insurers or pharmacy benefit managers (PBMs) from engaging in white bagging practices. It would ensure patients could choose which pharmacy they want to obtain their medications from and ensure in-network providers (like hospitals) would get paid for providing services, regardless of which pharmacy they obtained the medications from.

Three states (Louisiana, Minnesota and Vermont) currently have legislation prohibiting white bagging and nine other states are considering legislation to join them. 

“White bagging saves middlemen money, but creates waste, barriers to care and disruptions to the patient-provider relationship,” said Senator Ujifusa (D-Dist. 11, Portsmouth, Bristol). “Across the country, state legislators are looking to audit and rein in insurers and their PBMs. This bill shows Rhode Island is prepared to join the movement to restrain vertically integrated middlemen conglomerates from making money by limiting provider care for patients.”

The bill now heads to the House for consideration.

 

A federal ethics watchdog fired by President Trump is dropping a lawsuit challenging his dismissal. Head of the Office of Special Counsel Hampton Dellinger announced Thursday he's dropping the lawsuit in response to a ruling issued yesterday by a federal appeals court that allows him to be removed from his post while the case plays out.        SpaceX has once again lost contact with its Starship rocket during a test flight. The rocket launched from SpaceX's base in Texas on Thursday afternoon, but eight minutes into the flight, several engines appeared to cut off and the craft spun out of control before all communication was lost. During the last test flight back in January, the Starship rocket exploded, also about eight minutes after takeoff.        A New Mexico resident has tested positive for measles after their death. On Thursday, the state Health Department said the official cause of death hasn't been determined yet, but the unvaccinated adult didn't seek medical care before dying. Measles is spreading rapidly in West Texas, with 159 confirmed cases as of Tuesday.        The President says he'll "probably" extend the deadline of the TikTok ban if a deal isn't reached. On Thursday, Trump said he know's there's "a lot of interest" in the social media platform. When asked if he plans to extend the deadline if an American company doesn't buy the app, Trump said "Probably, yeah."        Butterflies are disappearing from the U.S. at a worrying pace. According to a new study published in the journal Science, their total populations declined by over 20-percent between 2000 and 2020. The study's lead author said in a statement that the numbers should be a "wake-up call."        "Mickey 17" is looking to get off to a good start at the box office. The film starring Robert Pattinson is projected to bring in between 18 and 20-million-dollars in its debut weekend. The movie features Pattinson as multiple versions of the same character, who is an expendable worker that can be reprinted back into existence after he dies.